NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.920
-0.075 (-3.76%)
At close: Oct 6, 2025, 4:00 PM EDT
1.920
0.00 (0.00%)
Pre-market: Oct 7, 2025, 6:23 AM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $6.07 million as of October 7, 2025. Its market cap has increased by 2.13% in one year.
Market Cap
6.07M
Enterprise Value
2.99M
1-Year Change
2.13%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $6.07M, a decrease of -69.84%. That is a compound annual growth rate of -22.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 6.30M | 84.14% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
| Jan 29, 2021 | 20.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |